Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Inc., 7221 [2018-03293]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 34 / Tuesday, February 20, 2018 / Notices
DEPARTMENT OF JUSTICE
Controlled
substance
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before April 23, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 09, 2017, Johnson Matthey
Inc., 2003 Nolte Drive, West Deptford,
NJ 08066, applied to be registered as a
bulk manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
sradovich on DSK3GMQ082PROD with NOTICES
Controlled
substance
Gamma Hydroxybutyric
Acid.
Marihuana .........................
Tetrahydrocannabinols .....
Dihydromorphine ...............
Difenoxin ...........................
Propiram ...........................
Amphetamine ....................
Methamphetamine ............
Lisdexamfetamine .............
Methylphenidate ................
Nabilone ............................
Cocaine .............................
Codeine .............................
Dihydrocodeine .................
Oxycodone ........................
Hydromorphone ................
VerDate Sep<11>2014
Drug
code
Schedule
2010
I
7360
7370
9145
9168
9649
1100
1105
1205
1724
7379
9041
9050
9120
9143
9150
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
17:55 Feb 16, 2018
Jkt 244001
Diphenoxylate ...................
Ecgonine ...........................
Hydrocodone .....................
Meperidine ........................
Methadone ........................
Methadone intermediate ...
Morphine ...........................
Thebaine ...........................
Oxymorphone ...................
Noroxymorphone ..............
Alfentanil ...........................
Remifentanil ......................
Sufentanil ..........................
Tapentadol ........................
Fentanyl ............................
Drug
code
9170
9180
9193
9230
9250
9254
9300
9333
9652
9668
9737
9739
9740
9780
9801
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the above-listed controlled substances
in bulk for sale to its customers.
Thebaine (9333) will be used to
manufacture other controlled substances
for sale in bulk to its customers.
In reference to drug codes 7360
(marihuana), and 7370 (THC), the
company plans to bulk manufacture
these drugs as synthetics. No other
activities for these drug codes are
authorized for this registration.
Dated: February 6, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–03293 Filed 2–16–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Taylor Animal Shelter; Order
On October 4, 2017, the Acting
Assistant Administrator, Diversion
Control Division, Drug Enforcement
Administration, issued an Order to
Show Cause proposing the revocation of
the DEA Certificate of Registration
issued to Taylor Animal Shelter of
Taylor, Michigan (Respondent). GX 1, at
1. The basis of the proposed action was
that, on June 30, 2017, Respondent’s
Michigan Controlled Substance Sodium
Pentobarbital Facility license lapsed,
and thus, it was ‘‘currently without
authority to handle controlled
substances in the State of Michigan, the
[S]tate in which [it is] registered with
the’’ Agency. Id.; see also 21 U.S.C.
§ 824(a)(3).
Following service of the Show Cause
Order, Respondent submitted a timely
written statement of position with
exhibits while waiving its right to a
hearing. In its position statement,
Respondent represented that its state
controlled substances registration was
renewed on October 30, 2017. Resp.’s
Statement at 3, ¶ 10. Respondent
attached a copy of a document which
states that it is a ‘‘Sodium Pentobarbital
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
7221
Permit for Practice of Animal
Euthanasia (Facility Permit).’’ Resp.’s
Statement, at Exhibit E. While much of
this document is unreadable, and it is
unclear from the document when this
permit was issued or expires,
Respondent provided an affidavit of the
Operations Manager for the Department
of Public Works of the City of Taylor,
Michigan, which states that on October
30, 2017, he received the renewed state
license for the facility. Affidavit of Matt
Bonza, at 2. Moreover, the Government
does not dispute that the facility has reobtained state authority to dispense
controlled substances. Request for Order
Dismissing Order to Show Cause, at 2.
As the Government acknowledges, the
sole basis for seeking revocation of
Respondent’s DEA registration was ‘‘its
lack of state authority to handle
controlled substances’’ and ‘‘this ground
for revocation no longer exists.’’ Id. The
Government thus seeks an order
dismissing the Order to Show Cause. Id.
at 3. Accordingly, I will grant the
Government’s request and dismiss the
Order to Show Cause. Id.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 824 and 28 CFR 0.100(b),
I order that the Order to Show Cause
issued to Taylor Animal Shelter be, and
it hereby is, dismissed. This Order is
effective immediately.
Dated: February 6, 2018.
Robert W. Patterson,
Acting Administrator.
[FR Doc. 2018–03298 Filed 2–16–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
James E. Ranochak, M.D.; Decision
and Order
On September 11, 2017, the Acting
Assistant Administrator, Diversion
Control Division, Drug Enforcement
Administration, issued an Order to
Show Cause to James E. Ranochak, M.D.
(hereinafter, Registrant), of Fort Wayne,
Indiana. The Show Cause Order
proposed the revocation of Registrant’s
DEA Certificate of Registration No.
AR1591913, on the ground that he
‘‘do[es] not have authority to handle
controlled substances in . . . Indiana,
the [S]tate in which [he is] registered
with the’’ Agency. GX 2, at 1 (citing 21
U.S.C. 823(f) and 824(a)(3)).
As to the jurisdictional basis of the
proceeding, the Show Cause Order
alleged that Registrant is registered ‘‘as
a practitioner in Schedules II [through]
E:\FR\FM\20FEN1.SGM
20FEN1
]]>Agencies
[Federal Register Volume 83, Number 34 (Tuesday, February 20, 2018)]
[Notices]
[Page 7221]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03293]
[[Page 7221]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before April 23, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
November 09, 2017, Johnson Matthey Inc., 2003 Nolte Drive, West
Deptford, NJ 08066, applied to be registered as a bulk manufacturer of
the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............. 2010 I
Marihuana............................. 7360 I
Tetrahydrocannabinols................. 7370 I
Dihydromorphine....................... 9145 I
Difenoxin............................. 9168 I
Propiram.............................. 9649 I
Amphetamine........................... 1100 II
Methamphetamine....................... 1105 II
Lisdexamfetamine...................... 1205 II
Methylphenidate....................... 1724 II
Nabilone.............................. 7379 II
Cocaine............................... 9041 II
Codeine............................... 9050 II
Dihydrocodeine........................ 9120 II
Oxycodone............................. 9143 II
Hydromorphone......................... 9150 II
Diphenoxylate......................... 9170 II
Ecgonine.............................. 9180 II
Hydrocodone........................... 9193 II
Meperidine............................ 9230 II
Methadone............................. 9250 II
Methadone intermediate................ 9254 II
Morphine.............................. 9300 II
Thebaine.............................. 9333 II
Oxymorphone........................... 9652 II
Noroxymorphone........................ 9668 II
Alfentanil............................ 9737 II
Remifentanil.......................... 9739 II
Sufentanil............................ 9740 II
Tapentadol............................ 9780 II
Fentanyl.............................. 9801 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances in bulk for sale to its customers. Thebaine (9333) will be
used to manufacture other controlled substances for sale in bulk to its
customers.
In reference to drug codes 7360 (marihuana), and 7370 (THC), the
company plans to bulk manufacture these drugs as synthetics. No other
activities for these drug codes are authorized for this registration.
Dated: February 6, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-03293 Filed 2-16-18; 8:45 am]
BILLING CODE 4410-09-P
